Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: A multicenter study
ConclusionsOxaliplatin-based PIPAC appears to be a safe treatment that offers good symptom control and promising survival for patients with advanced peritoneal disease.
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research
More News: Asbestosis | Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | Eloxatin | Gastric (Stomach) Cancer | Gastroenterology | Mesothelioma | Ovarian Cancer | Ovaries | Pain | Pancreas | Pancreatic Cancer | Peritoneal Cancer | Study | Surgery | Toxicology